Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 50 studies | 51% ± 17% | |
B cell | 47 studies | 53% ± 14% | |
pericyte | 37 studies | 52% ± 19% | |
macrophage | 34 studies | 50% ± 23% | |
smooth muscle cell | 25 studies | 42% ± 15% | |
conventional dendritic cell | 24 studies | 43% ± 19% | |
endothelial cell of lymphatic vessel | 23 studies | 43% ± 14% | |
non-classical monocyte | 22 studies | 34% ± 9% | |
classical monocyte | 22 studies | 31% ± 9% | |
plasma cell | 21 studies | 45% ± 13% | |
monocyte | 20 studies | 37% ± 19% | |
memory B cell | 20 studies | 54% ± 9% | |
naive B cell | 20 studies | 59% ± 13% | |
dendritic cell | 19 studies | 45% ± 16% | |
plasmacytoid dendritic cell | 19 studies | 55% ± 13% | |
microglial cell | 18 studies | 78% ± 17% | |
capillary endothelial cell | 17 studies | 41% ± 17% | |
endothelial cell of artery | 15 studies | 37% ± 15% | |
vein endothelial cell | 14 studies | 46% ± 21% | |
endothelial cell of vascular tree | 14 studies | 40% ± 19% | |
oligodendrocyte precursor cell | 11 studies | 31% ± 10% | |
glutamatergic neuron | 11 studies | 75% ± 25% | |
myeloid cell | 11 studies | 48% ± 23% | |
GABAergic neuron | 10 studies | 63% ± 31% | |
astrocyte | 10 studies | 40% ± 16% | |
plasmablast | 9 studies | 54% ± 21% | |
retinal cone cell | 8 studies | 59% ± 20% | |
mononuclear phagocyte | 7 studies | 36% ± 15% | |
retinal rod cell | 7 studies | 43% ± 15% | |
myofibroblast cell | 6 studies | 42% ± 23% | |
IgA plasma cell | 6 studies | 36% ± 12% | |
type II pneumocyte | 6 studies | 32% ± 6% | |
fibroblast | 6 studies | 32% ± 16% | |
neuron | 5 studies | 43% ± 22% | |
leukocyte | 5 studies | 48% ± 26% | |
IgG plasma cell | 5 studies | 38% ± 8% | |
hematopoietic stem cell | 5 studies | 34% ± 19% | |
pro-B cell | 5 studies | 53% ± 8% | |
immature B cell | 5 studies | 49% ± 16% | |
adipocyte | 5 studies | 23% ± 6% | |
cardiac muscle cell | 5 studies | 41% ± 4% | |
Mueller cell | 5 studies | 28% ± 6% | |
connective tissue cell | 5 studies | 43% ± 13% | |
interneuron | 5 studies | 65% ± 28% | |
hematopoietic precursor cell | 4 studies | 31% ± 10% | |
endothelial cell of sinusoid | 4 studies | 38% ± 13% | |
glomerular endothelial cell | 4 studies | 43% ± 4% | |
neutrophil | 4 studies | 34% ± 12% | |
glial cell | 4 studies | 31% ± 15% | |
megakaryocyte | 4 studies | 47% ± 15% | |
precursor B cell | 4 studies | 42% ± 14% | |
germinal center B cell | 4 studies | 50% ± 20% | |
club cell | 4 studies | 21% ± 4% | |
platelet | 3 studies | 19% ± 3% | |
natural killer cell | 3 studies | 22% ± 5% | |
tissue-resident macrophage | 3 studies | 37% ± 13% | |
muscle cell | 3 studies | 45% ± 7% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 52% ± 6% | |
Schwann cell | 3 studies | 28% ± 14% | |
oligodendrocyte | 3 studies | 32% ± 22% | |
mesothelial cell | 3 studies | 43% ± 19% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 19 studies | 47% ± 27% | |
peripheral blood | 9 studies | 25% ± 14% | |
lung | 8 studies | 24% ± 8% | |
eye | 7 studies | 34% ± 13% | |
heart | 6 studies | 33% ± 8% | |
lymph node | 4 studies | 26% ± 11% | |
adipose | 4 studies | 25% ± 3% | |
kidney | 3 studies | 20% ± 5% | |
bone marrow | 3 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 3556.07 | 652 / 653 | 95% | 11.20 | 574 / 605 |
adrenal gland | 100% | 3521.52 | 258 / 258 | 90% | 9.27 | 208 / 230 |
breast | 100% | 3952.38 | 459 / 459 | 90% | 8.18 | 1007 / 1118 |
brain | 88% | 4986.18 | 2335 / 2642 | 100% | 22.90 | 703 / 705 |
lung | 99% | 3043.98 | 575 / 578 | 75% | 7.06 | 864 / 1155 |
prostate | 96% | 1879.33 | 234 / 245 | 70% | 4.86 | 353 / 502 |
kidney | 78% | 1142.40 | 69 / 89 | 82% | 16.94 | 739 / 901 |
ovary | 100% | 3629.93 | 180 / 180 | 52% | 2.66 | 222 / 430 |
intestine | 96% | 2359.15 | 923 / 966 | 43% | 3.05 | 229 / 527 |
bladder | 100% | 2644.38 | 21 / 21 | 37% | 2.79 | 188 / 504 |
esophagus | 73% | 1622.26 | 1049 / 1445 | 62% | 4.16 | 113 / 183 |
uterus | 99% | 3619.76 | 168 / 170 | 34% | 4.12 | 157 / 459 |
skin | 38% | 540.28 | 696 / 1809 | 91% | 14.78 | 428 / 472 |
stomach | 49% | 862.18 | 175 / 359 | 62% | 5.46 | 177 / 286 |
adipose | 100% | 4717.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 15641.37 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4202.46 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6509.82 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 2249.28 | 842 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 29.74 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 96% | 14.00 | 77 / 80 |
pancreas | 5% | 57.28 | 17 / 328 | 85% | 6.99 | 151 / 178 |
tonsil | 0% | 0 | 0 / 0 | 58% | 4.14 | 26 / 45 |
liver | 8% | 93.23 | 19 / 226 | 38% | 2.00 | 153 / 406 |
peripheral blood | 44% | 3650.61 | 406 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_0001974 | Biological process | blood vessel remodeling |
GO_0071498 | Biological process | cellular response to fluid shear stress |
GO_0001947 | Biological process | heart looping |
GO_1905563 | Biological process | negative regulation of vascular endothelial cell proliferation |
GO_0002062 | Biological process | chondrocyte differentiation |
GO_0014902 | Biological process | myotube differentiation |
GO_0001764 | Biological process | neuron migration |
GO_0003138 | Biological process | primary heart field specification |
GO_0007521 | Biological process | muscle cell fate determination |
GO_0043537 | Biological process | negative regulation of blood vessel endothelial cell migration |
GO_0006959 | Biological process | humoral immune response |
GO_0035984 | Biological process | cellular response to trichostatin A |
GO_0060998 | Biological process | regulation of dendritic spine development |
GO_0003185 | Biological process | sinoatrial valve morphogenesis |
GO_0014033 | Biological process | neural crest cell differentiation |
GO_0030279 | Biological process | negative regulation of ossification |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0007519 | Biological process | skeletal muscle tissue development |
GO_0002931 | Biological process | response to ischemia |
GO_0000165 | Biological process | MAPK cascade |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0045663 | Biological process | positive regulation of myoblast differentiation |
GO_2000987 | Biological process | positive regulation of behavioral fear response |
GO_0051966 | Biological process | regulation of synaptic transmission, glutamatergic |
GO_0001958 | Biological process | endochondral ossification |
GO_0071374 | Biological process | cellular response to parathyroid hormone stimulus |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0046928 | Biological process | regulation of neurotransmitter secretion |
GO_0043523 | Biological process | regulation of neuron apoptotic process |
GO_0071277 | Biological process | cellular response to calcium ion |
GO_0010694 | Biological process | positive regulation of alkaline phosphatase activity |
GO_0048667 | Biological process | cell morphogenesis involved in neuron differentiation |
GO_0030182 | Biological process | neuron differentiation |
GO_0051963 | Biological process | regulation of synapse assembly |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0001568 | Biological process | blood vessel development |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0030220 | Biological process | platelet formation |
GO_0007399 | Biological process | nervous system development |
GO_0072102 | Biological process | glomerulus morphogenesis |
GO_0060025 | Biological process | regulation of synaptic activity |
GO_0098989 | Biological process | NMDA selective glutamate receptor signaling pathway |
GO_0003211 | Biological process | cardiac ventricle formation |
GO_0061333 | Biological process | renal tubule morphogenesis |
GO_0060045 | Biological process | positive regulation of cardiac muscle cell proliferation |
GO_0002467 | Biological process | germinal center formation |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_2001016 | Biological process | positive regulation of skeletal muscle cell differentiation |
GO_0050853 | Biological process | B cell receptor signaling pathway |
GO_0045652 | Biological process | regulation of megakaryocyte differentiation |
GO_0001782 | Biological process | B cell homeostasis |
GO_0048643 | Biological process | positive regulation of skeletal muscle tissue development |
GO_0098990 | Biological process | AMPA selective glutamate receptor signaling pathway |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0048666 | Biological process | neuron development |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_0007517 | Biological process | muscle organ development |
GO_0042100 | Biological process | B cell proliferation |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_2000111 | Biological process | positive regulation of macrophage apoptotic process |
GO_1904706 | Biological process | negative regulation of vascular associated smooth muscle cell proliferation |
GO_0007507 | Biological process | heart development |
GO_0007611 | Biological process | learning or memory |
GO_0002634 | Biological process | regulation of germinal center formation |
GO_2000727 | Biological process | positive regulation of cardiac muscle cell differentiation |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0030318 | Biological process | melanocyte differentiation |
GO_0072160 | Biological process | nephron tubule epithelial cell differentiation |
GO_0030154 | Biological process | cell differentiation |
GO_0051145 | Biological process | smooth muscle cell differentiation |
GO_0006915 | Biological process | apoptotic process |
GO_1904753 | Biological process | negative regulation of vascular associated smooth muscle cell migration |
GO_2001013 | Biological process | epithelial cell proliferation involved in renal tubule morphogenesis |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0003139 | Biological process | secondary heart field specification |
GO_0030501 | Biological process | positive regulation of bone mineralization |
GO_0055012 | Biological process | ventricular cardiac muscle cell differentiation |
GO_0098794 | Cellular component | postsynapse |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0016528 | Cellular component | sarcoplasm |
GO_0016607 | Cellular component | nuclear speck |
GO_0005829 | Cellular component | cytosol |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0042826 | Molecular function | histone deacetylase binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0003680 | Molecular function | minor groove of adenine-thymine-rich DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
Gene name | MEF2C |
Protein name | Myocyte-specific enhancer factor 2C (Myocyte enhancer factor 2C) Myocyte enhancer factor 2C |
Synonyms | hCG_36839 |
Description | FUNCTION: Transcription activator which binds specifically to the MEF2 element present in the regulatory regions of many muscle-specific genes. Controls cardiac morphogenesis and myogenesis, and is also involved in vascular development. Enhances transcriptional activation mediated by SOX18. Plays an essential role in hippocampal-dependent learning and memory by suppressing the number of excitatory synapses and thus regulating basal and evoked synaptic transmission. Crucial for normal neuronal development, distribution, and electrical activity in the neocortex. Necessary for proper development of megakaryocytes and platelets and for bone marrow B-lymphopoiesis. Required for B-cell survival and proliferation in response to BCR stimulation, efficient IgG1 antibody responses to T-cell-dependent antigens and for normal induction of germinal center B-cells. May also be involved in neurogenesis and in the development of cortical architecture (By similarity). Isoforms that lack the repressor domain are more active than isoform 1. . |
Accessions | D6RJG6 ENST00000625674.2 [Q06413-6] A0A0D9SFD0 ENST00000424173.6 [Q06413-6] ENST00000637481.1 D6RG14 ENST00000635898.1 ENST00000627717.2 ENST00000631026.2 ENST00000340208.9 [Q06413-5] ENST00000637732.1 [Q06413-3] D6R942 ENST00000629612.2 [Q06413-2] ENST00000514028.5 [Q06413-3] ENST00000437473.6 [Q06413-1] ENST00000510942.5 ENST00000502983.5 A0A9L9PYA3 ENST00000636294.1 [Q06413-1] A0A0R4J2G5 D6RC63 ENST00000502831.5 ENST00000513252.5 D6RCM6 ENST00000504921.7 [Q06413-1] ENST00000503075.1 ENST00000506554.5 D6RG21 D6RJA7 ENST00000509373.1 ENST00000707127.1 ENST00000508569.5 [Q06413-2] D6RJ95 ENST00000514015.5 [Q06413-3] ENST00000628656.2 [Q06413-4] A0A0D9SGF3 ENST00000506716.5 A0A0D9SG58 ENST00000507984.5 A0A1B0GVI4 ENST00000503554.4 ENST00000627170.2 A0A1B0GV32 ENST00000636998.1 [Q06413-3] Q06413 D6RB91 A0A0D9SFV9 ENST00000626391.2 ENST00000625585.2 A0A1B0GTW4 ENST00000636541.1 A0A0D9SET2 A0A0D9SGI5 ENST00000508610.5 D8L7E9 ENST00000627659.2 |